The legislation would require pharmacists to dispense only tamper-resistant pain pills, which cannot be crushed in order to be snorted or injected. But opponents say there is little data to support the claim that the tamper-resistant policy would reduce overdose deaths and express concern that the pills are sold primarily by large pharmaceutical companies like Endo and Pfizer.
Opponents are also concerned about cost. The bill anticipates it would raise the state’s TennCare expenses by $700,000 and overall Medicaid program costs by $1.4 million annually.
State Rep. Joey Hensley, MD, said he opposes the bill because he believes physicians can already write prescriptions for tamper-resistant drugs if they feel a patient might be prone to abuse.
“What this bill’s doing is favoring a certain drug company that makes these tamper-resistant drugs and we’re cutting out generic companies from making this,” Dr. Hensley said. “I just don’t know whether this technology is very expensive. I feel like if [a physician] wants a tamper-resistant drug, they can put it on the prescription.”
Related Articles on Pain Management:
Congress Targets ‘Gray Market’ Pharmacies Selling Overpriced Painkillers
St. Louis University Pain Researcher Awarded Grant to Study Cancer Pain
Florida County Likely to Extend Ban on New Pain Clinics
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
